ZNF141
Basic information
Region (hg38): 4:337814-384868
Previous symbols: [ "D4S90" ]
Links
Phenotypes
GenCC
Source:
- postaxial polydactyly type A (Supportive), mode of inheritance: AR
- polydactyly, postaxial, type A6 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Postaxial polydactyly type A6 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 23160277 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF141 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 14 | 10 | 29 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 11 | 14 |
Variants in ZNF141
This is a list of pathogenic ClinVar variants found in the ZNF141 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-343842-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
4-343849-A-G | not specified | Uncertain significance (Nov 12, 2021) | ||
4-343890-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
4-344340-G-A | ZNF141-related disorder | Benign (Apr 21, 2020) | ||
4-344401-A-C | not specified | Uncertain significance (Mar 15, 2024) | ||
4-344402-G-A | ZNF141-related disorder | Likely benign (Sep 03, 2020) | ||
4-344408-T-TGA | not specified • ZNF141-related disorder | Benign (Jan 02, 2020) | ||
4-344411-G-C | ZNF141-related disorder | Benign (Aug 21, 2019) | ||
4-344412-ATC-A | not specified • ZNF141-related disorder | Benign (Jan 06, 2020) | ||
4-344414-C-G | not specified | Uncertain significance (Apr 01, 2024) | ||
4-344416-T-C | ZNF141-related disorder | Benign (Apr 21, 2020) | ||
4-358406-G-A | ZNF141-related disorder | Benign (Sep 18, 2019) | ||
4-372673-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
4-372790-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
4-372799-A-G | not specified | Uncertain significance (Aug 04, 2021) | ||
4-372807-A-G | Benign (Dec 31, 2019) | |||
4-372823-G-A | ZNF141-related disorder | Benign (Jul 31, 2018) | ||
4-372828-A-C | not specified | Uncertain significance (May 09, 2024) | ||
4-372877-G-A | not specified | Uncertain significance (May 10, 2024) | ||
4-372888-G-A | not specified | Likely benign (Mar 22, 2023) | ||
4-372924-C-T | Likely benign (Oct 16, 2017) | |||
4-372948-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
4-373164-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
4-373165-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
4-373251-A-G | not specified | Uncertain significance (Dec 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF141 | protein_coding | protein_coding | ENST00000240499 | 4 | 47051 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.104 | 0.784 | 125700 | 0 | 4 | 125704 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.224 | 232 | 242 | 0.959 | 0.0000116 | 3148 |
Missense in Polyphen | 74 | 87.384 | 0.84683 | 1161 | ||
Synonymous | 0.0493 | 85 | 85.6 | 0.993 | 0.00000389 | 816 |
Loss of Function | 1.23 | 2 | 4.97 | 0.403 | 2.10e-7 | 60 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000871 | 0.0000871 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation as a repressor. Plays a role in limb development. {ECO:0000269|PubMed:23160277}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- loftool
- rvis_EVS
- 0.8
- rvis_percentile_EVS
- 87.49
Haploinsufficiency Scores
- pHI
- 0.394
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.305
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;anatomical structure morphogenesis;limb morphogenesis
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding